Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ascend Wellness Holdings, Inc. stock logo
AAWH
Ascend Wellness
$0.29
$0.34
$0.27
$1.23
$59.29M1.03119,792 shs108,100 shs
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$4.08
-12.8%
$5.06
$3.42
$7.20
$229.35M1.821.56 million shs4.79 million shs
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
$3.25
-4.4%
$2.85
$2.12
$5.80
$322.82M1.941.55 million shs1.68 million shs
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
$9.74
-5.3%
$10.75
$4.81
$27.50
$325.55MN/A249,968 shs383,374 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ascend Wellness Holdings, Inc. stock logo
AAWH
Ascend Wellness
0.00%-1.86%-6.45%-15.53%-67.42%
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.00%-30.26%-25.68%-8.52%-28.67%
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
0.00%-4.97%+41.92%+1.25%+21.27%
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
0.00%-6.08%-22.14%+23.45%+973,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ascend Wellness Holdings, Inc. stock logo
AAWH
Ascend Wellness
N/AN/AN/AN/AN/AN/AN/AN/A
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.23 of 5 stars
0.02.00.00.01.00.80.6
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
1.4158 of 5 stars
3.51.00.00.02.90.00.0
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
2.0681 of 5 stars
3.50.00.00.00.03.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ascend Wellness Holdings, Inc. stock logo
AAWH
Ascend Wellness
4.00
Strong BuyN/AN/A
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.67
Strong BuyN/AN/A
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
3.00
Buy$10.14212.09% Upside
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
3.00
Buy$37.50285.01% Upside

Current Analyst Ratings Breakdown

Latest AAWH, MBX, AQST, and ACB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/17/2025
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
6/2/2025
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$7.00
5/15/2025
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
4/10/2025
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
Citizens Jmp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$38.00
4/10/2025
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$44.00 ➝ $44.00
4/10/2025
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Outperform$38.00
4/2/2025
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
(Data available from 6/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ascend Wellness Holdings, Inc. stock logo
AAWH
Ascend Wellness
$518.59M0.11$0.04 per share6.64$0.69 per share0.42
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$200.35M1.14$0.22 per share18.26$8.18 per share0.50
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
$57.56M5.61N/AN/A($0.66) per share-4.92
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ascend Wellness Holdings, Inc. stock logo
AAWH
Ascend Wellness
-$48.21M-$0.40N/AN/AN/A-15.47%-72.18%-9.55%N/A
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$48.62M$0.0537.099.27N/A1.32%0.13%0.10%8/6/2025 (Estimated)
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
-$44.14M-$0.59N/AN/AN/A-100.02%N/A-50.31%8/5/2025 (Estimated)
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest AAWH, MBX, AQST, and ACB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/18/2025Q4 2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.11$0.07-$0.04-$0.24$88.85 million$63.34 million
5/12/2025Q1 2025
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
-$0.17-$0.24-$0.07-$0.24$12.23 million$8.72 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ascend Wellness Holdings, Inc. stock logo
AAWH
Ascend Wellness
N/AN/AN/AN/AN/A
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
N/AN/AN/AN/AN/A
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ascend Wellness Holdings, Inc. stock logo
AAWH
Ascend Wellness
2.61
1.47
0.80
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.07
3.30
1.60
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
N/A
4.87
4.48
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Ascend Wellness Holdings, Inc. stock logo
AAWH
Ascend Wellness
17.31%
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
32.45%
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
N/A

Insider Ownership

CompanyInsider Ownership
Ascend Wellness Holdings, Inc. stock logo
AAWH
Ascend Wellness
22.38%
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
8.35%
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
52.19%
CompanyEmployeesShares OutstandingFree FloatOptionable
Ascend Wellness Holdings, Inc. stock logo
AAWH
Ascend Wellness
2,300204.44 million166.44 millionNot Optionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,07356.21 million56.21 millionOptionable
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
16099.33 million91.03 millionOptionable
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
3633.42 millionN/AN/A

Recent News About These Companies

Ascendis Pharma initiated with an Outperform at RBC Capital
MBX Biosciences initiated with an Outperform at Citizens JMP
MBX Biosciences adds biotech veteran to board

New MarketBeat Followers Over Time

Media Sentiment Over Time

Ascend Wellness stock logo

Ascend Wellness OTC:AAWH

$0.29 0.00 (0.00%)
As of 06/20/2025 03:58 PM Eastern

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in New York, New York.

Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$4.08 -0.60 (-12.82%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$4.10 +0.01 (+0.37%)
As of 06/20/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Aquestive Therapeutics stock logo

Aquestive Therapeutics NASDAQ:AQST

$3.25 -0.15 (-4.41%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$3.26 +0.02 (+0.46%)
As of 06/20/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. Its proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. The company's proprietary pipeline of complex molecule product includes AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; and Anaphylm, an epinephrine sublingual film for the emergency treatment of allergic reactions, including anaphylaxis. In addition, it develops Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.

MBX Biosciences stock logo

MBX Biosciences NYSE:MBX

$9.74 -0.54 (-5.25%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$9.74 -0.01 (-0.05%)
As of 06/20/2025 05:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies designed as a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist prodrug for treating obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.